News Channels

01 Sep 2020 Aegis Life, Inc. Launches to Fight COVID-19 via DNA Vaccines and Therapeutics Enabled by Proprietary Fusogenix Delivery Technology
01 Sep 2020 Arena Pharmaceuticals Announces First Subject Dosed in Phase 2 Trial Evaluating Etrasimod in Alopecia Areata
01 Sep 2020 Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
01 Sep 2020 Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
01 Sep 2020 Provention Bio Announces Initiation of Phase 2b PROACTIVE Study of PRV-015 (anti-IL-15) in Non-responsive Celiac Disease
01 Sep 2020 Positive headline results from the Vyepti (eptinezumab-jjmr) RELIEF study
01 Sep 2020 Transcenta Announces First Patient Dosed in Phase I China Trial of Claudin18.2 Targeting Monoclonal Antibody TST001
01 Sep 2020 Innovent Announces First Subject Dosed in the Phase 1 Clinical Trial of Anti-IL-23 Monoclonal Antibody
01 Sep 2020 Omeros’ Investigational New Drug Application for OMS906 Cleared by FDA
01 Sep 2020 MaaT Pharma Announces Positive Data for Its Lead Microbiome Biotherapeutic MaaT013 in Intestinal Acute Graft-versus-Host-Disease at the Virtual 46th Annual Meeting of the EBMT
01 Sep 2020 Elektrofi and LEO Pharma Enter Licensing Agreement for Development of High-Concentration, Low-Volume Formulations of Investigational Monoclonal Antibodies
01 Sep 2020 Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2 Study of EMB-001 in Cocaine Use Disorder
01 Sep 2020 Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease
01 Sep 2020 Domain Therapeutics enters into a new collaboration agreement with Pfizer Inc. to profile signaling pathways of GPCRs across multiple diseases
01 Sep 2020 Biotest achieves another important clinical milestone for IgG Next Generation
01 Sep 2020 SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
01 Sep 2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)
01 Sep 2020 Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH
01 Sep 2020 Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups
01 Sep 2020 Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up